Using a combination of whole genome and targeted region sequencing of metastatic ChRCC cases, Casuscelli et al. found enrichment of TP53 (58%) and PTEN (24%) mutations and duplication of > 3 chromosomes (25%) (11). This evidence concerns the gene TP53 and chromophobe renal cell carcinoma.